#Gameboy color emu emuparadise registration

The date of this Offering Circular is, 2016. The approximate date of proposed sale to the public: As soon as practicable after the offering is qualified (the в€ѕffective DateВ”).

#Gameboy color emu emuparadise registration

THESE SECURITIES ARE BEING OFFERED PURSUANT TO AN EXEMPTION FROM REGISTRATION WITH THE COMMISSION HOWEVER, THE COMMISSION HAS NOT MADE AN INDEPENDENT DETERMINATION THAT THE SECURITIES OFFERED HEREUNDER ARE EXEMPT FROM REGISTRATION. STATES SECURITIES AND EXCHANGE COMMISSION DOES NOT PASS UPON THE MERITS OF, OR GIVE ITS APPROVAL TO, ANY SECURITIES OFFERED OR THE TERMS OF THE OFFERING, NOR DOES IT PASS UPON THE ACCURACY OR COMPLETENESS OF ANY OFFERING CIRCULAR OR OTHER SELLING Please read В“Risk Factors,В” beginning on of this Offering Circular about the risks you should consider before investing.Д«efore deducting expenses of the Offering, which are estimated to be approximately $15,000. Investing in our Common Stock involves a high degree of risk, including the risk that you could lose all of your The mailing address of our office is: Suite 200, 265 Rimrock Road, North York, Ontario, Canada, M3J3C6. Pharmaceuticals amended its bylaws and filed articles of continuance with the Wyoming Secretary of State and transferred its corporate domicile from Delaware to the State of Wyoming. On JanuaryВ 15, 2010, the Company changed its name to Easton Pharmaceuticals Inc. The Company changed its name to LAM Industries and amended its articles of incorporation on MarchВ 4, 2009.

In July of 1998, the Company was incorporatedДЄs L.A.M. The exact name of the Issuer is Easton Pharmaceuticals Inc. Investors will not be entitled to a refund and could lose their entire investment. In the Offering will become immediately available to us and may be used as they are accepted. Since the Offering is being conducted on a В“best effortsВ” basis, there is no minimum number of Shares that must be sole, meaning we will retain any proceeds from the sale of the Shares sold in this Offering. If all of the Shares are purchased, the gross proceeds to us will be $5,000,000. The Shares will be offered for sale at a price of $0.003 per Share. On our behalf, the officers will rely on the safe harbor from broker-dealer registration, set out in Rule 3a4-1 under the Securities Exchange Act of 1934. The officers will not receive any commission or any other remuneration for these sales. The offering is being conducted on a В“bestД®ffortsВ” basis, which means that our officers will use their commercially reasonable best efforts in an attempt to sell the Shares. We will continue the offering until Shares with anДЄggregate sales price of $5,000,000 have been sold, or until MarchВ 31, 2016, whichever is earlier. This offering is being made on a В“best effortsВ” basis. Per share (the в€јommon StockВ”) at a purchase price per share of $0.003, up to an aggregate purchase price of $5,000,000. Pharmaceuticals Inc., a Wyoming corporation (в€ѕaston PharmaceuticalsВ” the в€јompany,В” or В“weВ”) hereby offers (the В“OfferingВ”) 1,666,666,666 shares (the В“SharesВ”) of its common stock, par value $0.0001